Näytetään tulokset 1 - 10 / 15
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi

Pioglitazone and bladder cancer risk : a multipopulation pooled, cumulative exposure analysis

Vertaisarvioitu
DOI
10.1007/s00125-014-3456-9
Levin, Daniel; Buchan, Iain E; Bowker, Samantha L; Minhas-Sandhu, Jasjeet K; Zafari, Zafar; Marra, C...
Diabetologia2015

Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate Pioglitazone

Vertaisarvioitu
DOI
10.1124/dmd.116.070375
Itkonen, Matti K.; Tornio, Aleksi; Neuvonen, Mikko; Neuvonen, Pertti J.; Niemi, Mikko; Backman, Jann...
Drug metabolism and disposition2016

Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis

Vertaisarvioitu
DOI
10.1007/s00125-014-3456-9
Levin Daniel, Bell Samira, Sund Reijo, Hartikainen Sirpa A, Tuomilehto Jaakko, Pukkala Eero, Keskimä...
DIABETOLOGIA2014

FGF21 Contributes to Metabolic Improvements Elicited by Exenatide and Pioglitazone in Patients with Type 2 Diabetes

Vertaisarvioitu
Avoin saatavuus
DOI
10.1152/ajpendo.00050.2022
Samms, Ricardo J; Cheng, Christine C; Fourcaudot, Marcel; Heikkinen, Sami; Khattab, Ahmed; Adams, Jo...
American journal of physiology : endocrinology and metabolism2022

Effects of pioglitazone, ß-naphthoflavone and aflatoxin B1 on gene expression profiles in human trophoblasts in vitro

Avoin saatavuus
El-Dairi, Rami
Publications of the University of Eastern Finland. Dissertations in Health Sciences2021

Peroxisome proliferator activated receptor gamma (PPAR-gamma) ligand pioglitazone regulated gene networks in term human primary trophoblast cells

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.reprotox.2018.07.077
Dairi, Rami El; Huuskonen, Pasi; Pasanen, Markku; Rysä, Jaana
Reproductive toxicology2018

The effect of alogliptin and pioglitazone combination therapy on various aspects of beta-cell function in patients with recent-onset type 2 diabetes

Vertaisarvioitu
DOI
10.1530/EJE-13-0639
van Raalte, Daniel H.; van Genugten, Renate E.; Eliasson, Bjorn; Moller-Goede, Diane L.; Mari, Andre...
European journal of endocrinology2014

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.

Vertaisarvioitu
DOI
10.1007/s00125-011-2447-3
Eliasson, Björn; Möller-Goede , D; Eeg-Olofsson, K; Wilson, D; Cederholm, J; Fleck, P; Diamant, M; T...
Diabetologia2012

ZnO Q-Dots-Induced Apoptosis Was Coupled with the Induction of PPAR gamma in Acute Promyelocytic Leukemia Cells; Proposing a Novel Application of Nanoparticles in Combination with Pioglitazone

Vertaisarvioitu
DOI
10.1007/s10876-021-01992-y
Esmaeili Shadi, Pourbagheri-Sigaroodi Atieh, Yousefi Amir-Mohammed, Fakhroueian Zahra, Momeny Majid,...
Journal of Cluster Science2022

Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta‐analysis

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/cen.14983
Melin, Johanna M.; Forslund, Maria; Alesi, Simon J.; Piltonen, Terhi; Romualdi, Daniela; Spritzer, P...
Clinical endocrinology2023

Pioglitazone and bladder cancer risk : a multipopulation pooled, cumulative exposure analysis

Vertaisarvioitu
DOI
10.1007/s00125-014-3456-9
2015

Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate Pioglitazone

Vertaisarvioitu
DOI
10.1124/dmd.116.070375
2016

Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis

Vertaisarvioitu
DOI
10.1007/s00125-014-3456-9
2014

FGF21 Contributes to Metabolic Improvements Elicited by Exenatide and Pioglitazone in Patients with Type 2 Diabetes

Vertaisarvioitu
Avoin saatavuus
DOI
10.1152/ajpendo.00050.2022
2022

Effects of pioglitazone, ß-naphthoflavone and aflatoxin B1 on gene expression profiles in human trophoblasts in vitro

Avoin saatavuus
2021

Peroxisome proliferator activated receptor gamma (PPAR-gamma) ligand pioglitazone regulated gene networks in term human primary trophoblast cells

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.reprotox.2018.07.077
2018

The effect of alogliptin and pioglitazone combination therapy on various aspects of beta-cell function in patients with recent-onset type 2 diabetes

Vertaisarvioitu
DOI
10.1530/EJE-13-0639
2014

Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.

Vertaisarvioitu
DOI
10.1007/s00125-011-2447-3
2012

ZnO Q-Dots-Induced Apoptosis Was Coupled with the Induction of PPAR gamma in Acute Promyelocytic Leukemia Cells; Proposing a Novel Application of Nanoparticles in Combination with Pioglitazone

Vertaisarvioitu
DOI
10.1007/s10876-021-01992-y
2022

Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta‐analysis

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/cen.14983
2023